COMMUNIQUÉS West-GlobeNewswire

PHM Announces Accretive Acquisition of Respiratory Services Focused Business
18/09/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
Phoenix Life Sciences International Completes Merger and Announces Global Production Strategy
18/09/2018
DENVER, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”), an adaptive healthcare solutions company, today announced its common stock is now publicly traded in the United [...]
Q-Apps Now Listed in the Epic App Orchard to Achieve Easier Data Interoperability
18/09/2018
App Orchard process streamlines access to health record information that significantly increases efficiency and value of Q-Centrix quality solutions for hospitals and health systems. Chicago, Sept. 18, 2018 (GLOBE [...]
ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
18/09/2018
EDISON, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
18/09/2018
MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]
Acasti Pharma Provides Clinical and Market Update
18/09/2018
TRILOGY phase 3 studies exceed 75% enrollment; on track to report topline results in 2019 LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator [...]
CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
18/09/2018
First Patient Dosed in Initial Immunotherapy Combination Trial Utilizing CBT’s Proprietary Assets PLEASANTON, Calif. and HANGZHOU, China, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China- [...]
Avisa Reports on Progress with Biomarker AV BreathTest™ Platform
18/09/2018
Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save hospital costs Proof-of-concept trial in Emergency Department pneumonia expected to be [...]
Hemispherx to Distribute Second Lot of Ampligen® for use in Multiple Indications in Argentina, the United States and Europe
18/09/2018
Ampligen supply will support product launch in Argentina, Expanded Access Programs for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the United States and Europe and pancreatic cancer in the [...]
ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
18/09/2018
Gencaro potentially the first genetically-targeted treatment for heart failure patients at risk for atrial fibrillation PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably [...]
Agritek Holdings, Inc. Announces Filing Of Form 10-Q Report With Return To Fully Reporting Status On OTCQB And Update To Shareholders
18/09/2018
LOS ANGELES, CA, Sept. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Wildflower Store Opening in New York’s Iconic Times Square in November
18/09/2018
VANCOUVER, British Columbia, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) is excited to announce that design work is completed for three prime locations in [...]
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
18/09/2018
Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology [...]
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
18/09/2018
Company announcement - No. 23/2018 Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia All primary and key secondary endpoints successfully [...]
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
18/09/2018
-- Company presentation scheduled for October 2, 2018 at 1:40 p.m. EDT -- SOUTH SAN FRANCISCO, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, [...]
Rexahn Pharmaceuticals to Present at the 5th NCI Pancreatic Cancer Symposium
18/09/2018
Preliminary Safety and Efficacy Data from the Ongoing Phase 2a Clinical Trial of RX-3117 in Combination with Abraxane® in Patients Newly Diagnosed with Metastatic Pancreatic Cancer will be presented ROCKVILLE, Md., Sept [...]
Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities
18/09/2018
IRVINE, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies ( [...]
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
18/09/2018
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic [...]
Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
18/09/2018
Remaining two of three planned Phase 3 pivotal trials now underway for Iterum’s lead antibiotic product candidate sulopenem Potential to be first and only oral and IV penem antibiotic available globally Top-line results [...]

Pages